Evogene Ltd. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Rehovot, Israel
SEC filing record 1 source field available
Fiscal year end
31 December
Evogene Ltd. has filed 429 SEC EDGAR filings since 26 Apr 2013

SEC filing history

Showing 176-200 of 429 matching filings.

Per page
25
Current page
8
6-K File 001-36187

6-K

Filing date
11 Aug 2021
Reporting date
11 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36187

6-K

Filing date
11 Aug 2021
Reporting date
11 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36187

6-K

Filing date
03 Aug 2021
Reporting date
03 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K/A File 001-36187

6-K/A

Filing date
07 Jul 2021
Reporting date
07 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36187

6-K

Filing date
06 Jul 2021
Reporting date
06 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36187

6-K

Filing date
01 Jul 2021
Reporting date
01 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36187

6-K

Filing date
23 Jun 2021
Reporting date
23 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36187

6-K

Filing date
23 Jun 2021
Reporting date
23 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36187

6-K

Filing date
26 May 2021
Reporting date
26 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36187

6-K

Filing date
19 Apr 2021
Reporting date
19 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36187

6-K

Filing date
25 Mar 2021
Reporting date
25 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-253300

EFFECT filing

Filing date
03 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36187

6-K

Filing date
03 Mar 2021
Reporting date
03 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
01 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
24 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36187

6-K

Filing date
19 Feb 2021
Reporting date
19 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
F-3 File 333-253300

F-3

Filing date
19 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87734

SC 13G/A

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87734

EVOGENE LTD.

Filing date
12 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87734

EVOGENE LTD

Filing date
12 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87734

SC 13G/A

Filing date
08 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36187

6-K

Filing date
01 Feb 2021
Reporting date
01 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87734

AMENDMENT NO. 2 TO SCHEDULE 13G

Filing date
21 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-240249

424B5

Filing date
14 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .